Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Test    symbols : Srne    save search

Sorrento Completes Acquisition of Virex Health, Will Commercialize Next-Generation at-Home Diagnostic Testing That Rivals PCR-Level Sensitivity for Daily Covid-19 Tests and Early Cancer Diagnosis
Published: 2022-02-01 (Crawled : 14:30) - globenewswire.com
SRNE | $0.024 -8.85% 57K twitter stocktwits trandingview |
Health Technology
| | O: 1.74% H: 0.85% C: -1.42%

diagnostic covid-19 health als acquisition covid test cancer
Sorrento Announces That Sorrento Mexico Has Sold Out of One Million COVISTIX Tests Last Week in Mexico
Published: 2022-01-19 (Crawled : 21:00) - globenewswire.com
SRNE | $0.024 -8.85% 57K twitter stocktwits trandingview |
Health Technology
| | O: 0.47% H: 5.59% C: -2.8%

test
Sorrento Therapeutics Mexico Wins Tender to Sell COVISTIX Tests to Mexico City Government
Published: 2022-01-13 (Crawled : 15:30) - globenewswire.com
SRNE | $0.024 -8.85% 57K twitter stocktwits trandingview |
Health Technology
| | O: 0.89% H: 0.0% C: 0.0%

therapeutics test
Sorrento Therapeutics Mexico Executes Second Contract for Sale of 10 Million COVISTIX Tests for Mexico Market
Published: 2021-12-27 (Crawled : 20:00) - biospace.com/
SRNE | $0.024 -8.85% 57K twitter stocktwits trandingview |
Health Technology
| | O: 2.78% H: 0.52% C: -5.42%

contract therapeutics test
Sorrento Announces COVISTIX COVID-19 Virus Rapid Antigen Detection Test Detects the Omicron Variant
Published: 2021-12-27 (Crawled : 15:30) - globenewswire.com
SRNE | $0.024 -8.85% 57K twitter stocktwits trandingview |
Health Technology
| | O: 2.78% H: 0.52% C: -5.42%

covid-19 covid test
Sorrento Therapeutics Mexico Executes Contract for Sale of 5 Million COVI-STIX Tests for Mexico Market
Published: 2021-11-22 (Crawled : 20:00) - globenewswire.com
SRNE | $0.024 -8.85% 57K twitter stocktwits trandingview |
Health Technology
| | O: -0.49% H: 0.16% C: -3.41%

test contract therapeutics
Sorrento Receives Brazilian Health Regulatory Agency (ANVISA) Approval for COVISTIX™ (COVID-19 Virus Antigen Detection Test) for Brazil
Published: 2021-11-03 (Crawled : 14:15) - globenewswire.com
SRNE | $0.024 -8.85% 57K twitter stocktwits trandingview |
Health Technology
| | O: -0.58% H: 7.09% C: 4.63%

covid brazil test approval
Sorrento Announces That COVISTIX™ (COVID-19 Virus Rapid Antigen Detection Test) Has Received a CE Mark and Registration of the Device
Published: 2021-10-20 (Crawled : 22:00) - biospace.com/
SRNE | $0.024 -8.85% 57K twitter stocktwits trandingview |
Health Technology
| | O: -0.59% H: 0.75% C: -2.99%

covid ce mark test device
Sorrento Announces an Independent Real-World Study That Reports Superior Sensitivity Results in Detecting COVID-19 Virus Infections in All-Comer General Population by COVISTIX as Compared to a Globally Leading Rapid Antigen Test
Published: 2021-09-19 (Crawled : 20:20) - globenewswire.com
SRNE | $0.024 -8.85% 57K twitter stocktwits trandingview |
Health Technology
| | O: -0.86% H: 2.09% C: -0.99%

covid test results injection infections
Sorrento Receives EUA Approval and Import License From Mexico Authority COFEPRIS For COVI-STIX™ (COVID-19 Virus Rapid Antigen Detection Test) and Plans Product Launch With Initial Shipments in July
Published: 2021-06-24 (Crawled : 18:00) - globenewswire.com
SRNE | $0.024 -8.85% 57K twitter stocktwits trandingview |
Health Technology
| | O: 0.44% H: 11.34% C: 10.13%

covid test license approval authorized
Sorrento Announces the Submission of a Marketing Authorization Application to COFEPRIS (Mexico) for COVI-STIX™ Rapid Detection Test of SARS-CoV-2 Viral Antigen
Published: 2020-12-30 (Crawled : 18:00) - globenewswire.com
SRNE | $0.024 -8.85% 57K twitter stocktwits trandingview |
Health Technology
| | O: 0.73% H: 5.49% C: 4.55%

test submission authorized sars-cov-2
Sorrento Announces It Has Submitted An Emergency Use Authorization (EUA) Application to the FDA for COVI-STIX™ Rapid Test for the Detection of SARS-CoV-2 Viral Antigen
Published: 2020-12-22 (Crawled : 00:02) - globenewswire.com
SRNE | $0.024 -8.85% 57K twitter stocktwits trandingview |
Health Technology
| | O: 6.51% H: 15.47% C: 11.31%

fda merge test authorized sars-cov-2 application emergency use authorization
Sorrento Receives Licensure From the State of California for Clinical Testing Laboratory (CLIA) Allowing for Clinical Sample Testing
Published: 2020-12-09 (Crawled : 01:08) - globenewswire.com
SRNE | $0.024 -8.85% 57K twitter stocktwits trandingview |
Health Technology
| | O: 10.51% H: 2.29% C: -5.96%

test
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.